MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-HR-03-0024930
Brawn Laboratories Limited - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹368.56 Cr
▲ 15% YoY
Net profit · FY 2025
₹33.01 Cr
Net margin 9%
EBITDA · FY 2025
₹52.55 Cr
EBITDA margin 14.3%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹99.5 Lakh
Issued & subscribed
Open charges
₹395.52 Cr
Satisfied ₹305.68 Cr
Company age
36 yrs
Est. 1990
Employees · EPFO
552
Provident fund records
About Brawn Laboratories Limited
Data last updated:
Brawn Laboratories Limited is a public limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 27 March 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U73200DL1990PLC039653. Its GSTIN is 07AAACB7151N2ZH (Delhi). The company holds 10 GST registrations, of which 8 are active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹99.5 Lakh. It is led by directors including Brij Raj Gupta and Mayank Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at C – 64 Lajpat Nagar – 1 Second Floor New Delhi, Delhi, India – 110024.
As per the financials filed for FY 2025, the company reported a revenue of ₹368.56 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹33.01 Cr (net margin 9%) and EBITDA of ₹52.55 Cr (EBITDA margin 14.3%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 15% over five years.
The company has about 552 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Brawn Labs and Brawn Herbals. As per MCA filings, the company has open charges of ₹395.52 Cr and satisfied charges of ₹305.68 Cr on record. Court records list 91 cases involving the company, including 56 filed by the company and 35 filed against it; 24 cases are pending. The company has 3 deals on record (3 secondary share transfers); the latest was in September 2019. Its 9 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 5 smaller; the largest is Caplin Steriles Limited with revenue of ₹377.24 Cr. The company has 19 MSME Form 1 returns on record between 2018 and 2024, listing 2,417 overdue payments to 66 micro and small suppliers.
Brawn Laboratories Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-03-0024930). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website brawnlabs.in.
Company details
CIN U73200DL1990PLC039653
Registration Number 039653
Incorporation Date 27 March 1990
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-HR-03-0024930
Recognitions & Rankings of Brawn Laboratories
Contact details
Brawn Laboratories Limited's registered office is in Delhi, Delhi. Its website is brawnlabs.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressC – 64 Lajpat Nagar – 1 Second Floor New Delhi, Delhi, India – 110024
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Brawn Laboratories Limited, buy the company report.
Comprehensive company report
Brawn Laboratories Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Brawn Laboratories operates two associated brands: Brawn Labs and Brawn Herbals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing, research, and global distribution services. | brawnlabs.com | |
| Herbal health and personal care products manufacturing and sales by Brawn Herbals. | brawnherbals.com |
Business activity
The main business activity of Brawn Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Brawn Laboratories Limited, buy the company report.
Financials of Brawn Laboratories Limited
FY 2024 filings availableBrawn Laboratories Limited reported revenue of ₹368.56 Cr (up 15% YoY) for FY 2025.
Revenue · FY 2025
₹368.56 Cr ▲ 15%
Net profit · FY 2025
₹33.01 Cr margin 9%
EBITDA · FY 2025
₹52.55 Cr margin 14.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 15%
3 years · compounded
▲ 13%
5 years · compounded
▲ 15%
EBITDA CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 20%
5 years · compounded
▲ 16%
Revenue has grown at a compounded annual rate (CAGR) of 15% over five years, including 15% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹52.55 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹33.01 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 14.3% | ||||
| Net Profit Margin | 9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Brawn Laboratories Limited, buy the company report.
Board of directors of Brawn Laboratories Limited
Brawn Laboratories has 4 current directors and 21 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brij Raj Gupta Also directs: Brawn Biotech Limited, Brawn Cosmetics and Herbals Private Limited | Director | 23 Apr 2003 | 23 Years 6 Months | Current |
| Mayank Jain | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Pooja Jha Also directs: Brawn Biotech Limited | Director | 28 Aug 2024 | 2 Years 1 Months | Current |
| Ankit Goyal | Director | 16 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Brawn Laboratories Limited is compared with the 9 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Caplin Steriles Limited | ₹377.24 Cr (FY 2025) | 18.0% | Chennai, Tamil Nadu, India | |||
| NGL Fine-Chem Limited | ₹376.89 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Unicure India Ltd | ₹369.12 Cr (FY 2025) | -12.0% | New Delhi, Delhi, India | |||
| Beta Drugs Limited | ₹368.79 Cr (FY 2025) | 24.0% | Baddi, Himachal Pradesh, India | |||
| Brawn Laboratories Limitedthis company | ₹368.56 Cr (FY 2025) | ₹33.01 Cr | 9% | 15.0% | 552 | Delhi, India |
| M. J. Biopharm Private Limited | ₹367.26 Cr (FY 2025) | 24.0% | Pune, Maharashtra, India | |||
| Biochem Pharmaceutical Industries Limited Part IX | ₹366.61 Cr (FY 2016) | 15.0% | Ahmedabad, Gujarat, India | |||
| Kopran Research Laboratories Limited | ₹365.89 Cr (FY 2025) | 13.0% | Mumbai, Maharashtra, India | |||
| Geltec Private Limited | ₹362.73 Cr (FY 2025) | 7.0% | Mumbai, Maharashtra, India | |||
| Mepro Pharmaceuticals Private Limited | ₹356.46 Cr (FY 2025) | 20.0% | Surendra Nagar, Gujarat, India |
To see the full peer comparison of Brawn Laboratories Limited, buy the company report.
Shareholding
The shareholding of Brawn Laboratories Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Brawn Laboratories Limited, buy the company report.
Charges & borrowings
Open charges
₹395.52 Cr
Satisfied charges
₹305.68 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 05 Jul 2025 | 101126303 | Others | ₹7.83 Lakh | Open | |
| 09 Jan 2025 | 101045354 | Others | ₹31.34 Lakh | Open | |
| 13 Dec 2024 | 101045357 | Others | ₹13.12 Lakh | Open | |
| 20 May 2023 | 100726593 | Citi Bank N.A. | ₹50 Cr | Open | |
| 03 Mar 2023 | 100685802 | Others | ₹80 Cr | Open |
To see the full charge records of Brawn Laboratories Limited, buy the company report.
Total charge records: 38 View all charges
Deals & funding
Brawn Laboratories Limited has 3 deals on record (3 secondary share transfers); the latest was in September 2019.
Total deals
3
Secondary share transfers
3
Deals on record (3 of 3)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2019 | Secondary share transfer | Undisclosed | Buyer: 4 individuals Seller: A B Pharma Private Limited , 3 individuals |
| Sep 2016 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Brawn Biotech Limited , Balmukund Gupta & Co., 2 individuals |
| Nov 2015 | Secondary share transfer | Undisclosed | Buyer: Brawn Biotech Limited , 3 individuals Seller: 4 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Brawn Laboratories Limited has 91 court cases on record: 56 filed by Brawn Laboratories, 35 filed against it. 24 cases are pending and 67 are disposed.
Total cases
91
Filed by the company
56
Filed against the company
35
Pending
24
Disposed
67
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 50 | 17 | 18 |
| District courts | 35 | 18 | 6 |
| Supreme Court | 6 | 0 | 0 |
Cases on record (5 of 91)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed against the company by Ajanta Pharma Limited W.S. Kane and Co | Pending |
| High Court | Court case (COMIP) | Filed by the company against Ajanta Pharma Limited | Pending |
| High Court, MAHARASHTRA | Interim or miscellaneous application | Filed by the company against Ajanta Pharma Limited | Pending |
| High Court, MAHARASHTRA | Court case (LPETN) | Filed against the company by Ajanta Pharma Limited | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed against the company by Ajanta Pharma Limited | Pending |
To see the full case history of Brawn Laboratories Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Brawn Laboratories Limited was last rated by Icra on 25 Oct 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Icra | 25 Oct 2021 |
To see the full credit ratings and regulatory alerts of Brawn Laboratories Limited, buy the company report.
MSME payment delays
Brawn Laboratories Limited has 19 MSME Form 1 returns on record between 2018 and 2024, listing 2,417 overdue payments to 66 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 66)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Dolphin International | |||
| Doctor Pack India Private Limited | |||
| N B Enterpreneurs | |||
| an individual supplier | |||
| Obvez Labs Private Limited |
To see the full MSME payment records of Brawn Laboratories Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Group structure & subsidiaries
Brawn Laboratories has 4 associated companies. This group structure data is as of FY 2024. The table lists each entity with its relationship and holding.
4
Associated companies
Employees & EPFO
Brawn Laboratories Limited has a workforce of 552 employees on its EPFO records as of Mar 31, 2025, across 1 active EPFO establishment.
Employee count
552
Active EPFO establishments
1
Employee growth
24.32%
GST
Brawn Laboratories has 10 GST registrations: 8 active and 2 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
10
Active
8
Cancelled / inactive
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAACB7151N2ZH | Delhi | Active | 13 Dec 2017 |
| 07AAACB7151N3ZG | Delhi | Active | 06 Jun 2022 |
| 06AAACB7151N1ZK | Haryana | Active | 01 Jul 2017 |
| 24AAACB7151N1ZM | Gujarat | Active | 01 Dec 2017 |
To see the full GST registrations and return filing status of Brawn Laboratories Limited, buy the company report.
Recent activity
Brawn Laboratories Limited has 25 board changes on record since 2003: 4 appointments and 21 cessations. The latest: Mayank Jain ceased to be Additional Director on 29 Sep 2024.
AGM
Brawn Laboratories Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.08 Cr with Charge ID 101126303 was registered on 05 Jul 2025.
Charges
A charge with Citi Bank N.A. of Rs. 150.00 Cr registered on 03 Mar 2022 with Charge ID 100543263 was modified on 30 Jan 2025.
Charges
A charge with Hdfc Bank Limited of Rs. 115.00 Cr registered on 03 Jun 2022 with Charge ID 100582771 was modified on 23 Jan 2025.
Charges
A charge with Others amounted to Rs. 0.31 Cr with Charge ID 101045354 was registered on 09 Jan 2025.
Charges
A charge with Others amounted to Rs. 0.13 Cr with Charge ID 101045357 was registered on 13 Dec 2024.
Charges
A charge with Others of Rs. 80.00 Cr registered on 03 Mar 2023 with Charge ID 100685802 was modified on 16 Nov 2024.
Ceased
Mayank Jain ceased to be Additional Director.
Ceased
Pooja Jha ceased to be Additional Director.
Appointed
Mayank Jain was appointed as Director.
Appointed
Pooja Jha was appointed as Director.
Filing
Brawn Laboratories Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
106 earlier events are in the company report.
Frequently asked questions
Brawn Laboratories is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 27 March 1990 (36+ years old) and is registered under CIN U73200DL1990PLC039653.
Brawn Laboratories has 4 current directors:
- Brij Raj Gupta - Director
- Mayank Jain - Director
- Pooja Jha - Director
- Ankit Goyal - Director
The latest financial statements of Brawn Laboratories on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Brawn Laboratories is 07AAACB7151N2ZH, registered in Delhi. The company has 10 GST registrations in all, of which 8 are active and 2 are cancelled or inactive. Other active GSTINs include 07AAACB7151N3ZG (Delhi), 06AAACB7151N1ZK (Haryana), 24AAACB7151N1ZM (Gujarat).
The CIN (Corporate Identification Number) of Brawn Laboratories is U73200DL1990PLC039653. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Brawn Laboratories has 91 court cases on record: 56 filed by the company and 35 filed against it. 24 are pending. Most are in the high courts.
Brawn Laboratories was incorporated on 27 March 1990, making it 36+ years old. It is registered with the Registrar of Companies, Delhi.
Brawn Laboratories has 3 deals on record (3 secondary share transfers); the latest was in September 2019.
The peers of Brawn Laboratories by revenue are Caplin Steriles Limited, NGL Fine-Chem Limited, Unicure India Ltd, Beta Drugs Limited, M. J. Biopharm Private Limited and 4 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Mayank Jain ceased to be Additional Director on 29 Sep 2024. Pooja Jha ceased to be Additional Director on 29 Sep 2024. Mayank Jain was appointed as Director on 28 Aug 2024. Brawn Laboratories has 25 board changes on record in total.
Yes, Brawn Laboratories is registered as a medium enterprise under Udyam registration (number: UDYAM-HR-03-0024930).
Brawn Laboratories has 19 MSME Form 1 returns on record between 2018 and 2024, listing 2,417 overdue payments to 66 micro and small suppliers. The latest return was filed on 30 Apr 2024.